Treatment News : Booze Doesn’t Affect Treatment Failure or CD4 Count

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » August 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


August 7, 2013

Booze Doesn’t Affect Treatment Failure or CD4 Count

A new study argues that consumption of alcohol appears unrelated to CD4 levels or treatment failure rates—although heavy drinkers are more likely to interrupt their antiretroviral (ARV) regimen, aidsmap reports. Publishing their findings in the Journal of Acquired Immune Deficiency Syndromes, researchers conducted a seven-year prospective cohort study of 2,982 people with HIV who were beginning ARVs for the first time and 2,085 people with HIV who did not start treatment, all of them drawn from the Swiss HIV Cohort Study.

Among those beginning HIV therapy for the first time, 241 (8 percent) experienced virologic failure during the study. Alcohol consumption proved unrelated to treatment failure. A total of 449 (15 percent) participants interrupted their ARVs for a week or longer without authorization from a physician. Those who were classified as posing severe risks to their health with drinking—consuming more than 40 grams of alcohol per week for women and 60 grams for men—were 2.24 times more likely to interrupt their treatment regimen when compared with those who were light drinkers or who did not drink.

The study found no link between CD4 counts and alcohol consumption in either group of study participants.

The researchers acknowledge that this topic is unsettled, writing, “Our data contribute valuable knowledge to the controversy over whether alcohol has an influence on HIV surrogates or not.”

To read a POZ story on false beliefs that HIV meds and alcohol are a toxic mix, click here.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: Alcohol consumption, HIV, CD4 levels, aidsmap, antiretroviral, Journal of Acquired Immune Deficiency Syndromes, Swiss HIV Cohort Study, treatment interruption, virologic failure.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:

  comments 1 - 2 (of 2 total)    

Ken, Atlanta, 2013-08-09 19:29:28
Comparing 5000 random people who may or may not drink and may or may not start treatment is an absurd way to draw conclusions on the effects of alcohol. Give people alcohol, and measure the effects for the next 48 hours, fools! It’s called the scientific method.

Davina, Greenfield, 2013-08-08 18:38:02
this is not true, and is irresponsible. there are a lot of us. who drink massive amounts and forget to eat, forget to take their pills, how can you publish this.

comments 1 - 2 (of 2 total)    

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.